Nigil Haroon, MD, PhD, DM, FRCPC

Nigil Haroon, MD, PhD, DM, FRCPC

University of Toronto

H-index: 40

North America-Canada

About Nigil Haroon, MD, PhD, DM, FRCPC

Nigil Haroon, MD, PhD, DM, FRCPC, With an exceptional h-index of 40 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of Ankylosing Spondylitis.

His recent articles reflect a diverse array of research interests and contributions to the field:

P163 Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

E068 Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 …

Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings

Prostaglandin E2/EP4 axis is upregulated in spondyloarthritis and contributes to radiographic progression

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study

Understanding COVID‐19 Risk in Patients With Immune‐Mediated Inflammatory Diseases: A Population‐Based Analysis of SARS–CoV‐2 Testing

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

Nigil Haroon, MD, PhD, DM, FRCPC Information

University

Position

Associate Professor . Clinician Scientist University Health Network

Citations(all)

17568

Citations(since 2020)

9928

Cited By

11851

hIndex(all)

40

hIndex(since 2020)

30

i10Index(all)

85

i10Index(since 2020)

65

Email

University Profile Page

University of Toronto

Google Scholar

View Google Scholar Profile

Nigil Haroon, MD, PhD, DM, FRCPC Skills & Research Interests

Ankylosing Spondylitis

Top articles of Nigil Haroon, MD, PhD, DM, FRCPC

Title

Journal

Author(s)

Publication Date

P163 Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

Martin Rudwaleit

Matthew A Brown

Floris Alexander van Gaalen

Nigil Haroon

Lianne S Gensler

...

2024/4/1

E068 Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 …

Xenofon Baraliakos

Sofia Ramiro

Marina Magrey

Martin Rudwaleit

Nigil Haroon

...

2024/4/1

Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings

Archita Srinath

Akihiro Nakamura

Nigil Haroon

2024/2/7

Prostaglandin E2/EP4 axis is upregulated in spondyloarthritis and contributes to radiographic progression

Clinical Immunology

Daniele Mauro

Archita Srinath

Giuliana Guggino

Vicky Nicolaidou

Stefania Raimondo

...

2023/6/1

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study

Rheumatology

Patricia Remalante-Rayco

Adrian I Espiritu

Yassir Daghistani

Tina Chim

Eshetu Atenafu

...

2023/10/4

Understanding COVID‐19 Risk in Patients With Immune‐Mediated Inflammatory Diseases: A Population‐Based Analysis of SARS–CoV‐2 Testing

Arthritis care & research

Lihi Eder

Ruth Croxford

Aaron M Drucker

Arielle Mendel

Bindee Kuriya

...

2023/2

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Annals of the rheumatic diseases

Désirée Van Der Heijde

Atul Deodhar

Xenofon Baraliakos

Matthew A Brown

Hiroaki Dobashi

...

2023/4/1

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

Annals of the rheumatic diseases

Victoria Navarro-Compán

Anne Boel

Annelies Boonen

Philip J Mease

Maxime Dougados

...

2023/6/1

Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in adult patients with immune-mediated inflammatory diseases

The Journal of Immunology Author Choice

Michelle W Cheung

Roya M Dayam

Janna R Shapiro

Jaclyn C Law

Gary YC Chao

...

2023/8/8

Clinical characteristics of psoriatic arthritis and axSpA patients with uveitis

Revista Colombiana de Reumatología (English Edition)

Vanessa Ocampo

Mitchell Sutton

Vinod Chandran

Nigil Haroon

Alexander Kaplan

...

2023/7/1

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global …

Annals of the rheumatic diseases

Pedro M Machado

Martin Schäfer

Satveer K Mahil

Jean Liew

Laure Gossec

...

2023/5/1

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis

The Journal of Rheumatology

Robert D Inman

Marco Garrido-Cumbrera

Jonathan Chan

Martin Cohen

Artur J de Brum-Fernandes

...

2023/5/1

POS0668 low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2B/3 trials

Martin Rudwaleit

M Brown

FA Van Gaalen

N Haroon

LS Gensler

...

2023/6/1

Methods of treating spondyloarthritis or symptoms thereof

2023/12/21

ERAP1 and the return of the UPR in ankylosing spondylitis

Nigil Haroon

Robert D Inman

2023/3

POS1106 ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 …

X Baraliakos

S Ramiro

M Magrey

Martin Rudwaleit

N Haroon

...

2023/6/1

Faibles taux d’uvéites chez les patients atteints de spondyloarthrite axiale traités par bimékizumab: résultats regroupés des essais de phase IIb/III

Revue du Rhumatisme

M Dougados

M Rudwaleit

MA Brown

FA Van Gaalen

N Haroon

...

2023/12/1

Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score

Journal of Clinical Medicine

Tarimobo M Otobo

Mirkamal Tolend

Arthur B Meyers

Iwona Sudol-Szopinska

Sayali Joshi

...

2023/4/6

Minimal Impact of the COVID‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory …

ACR Open Rheumatology

Philip C Robinson

Pedro M Machado

Nigil Haroon

Lianne S Gensler

John D Reveille

...

2022/9

Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis

Annals of the Rheumatic Diseases

Timothy SH Kwok

Mitchell Sutton

Daniel Pereira

Richard J Cook

Vinod Chandran

...

2022/12/1

See List of Professors in Nigil Haroon, MD, PhD, DM, FRCPC University(University of Toronto)